{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:38:00Z","timestamp":1794886680769,"version":"4.9.1"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41581-021-00429-z","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:45:49Z","timestamp":1622547949000},"page":"575-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":248,"title":["Nitric oxide signalling in kidney regulation and cardiometabolic health"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-8729","authenticated-orcid":false,"given":"Mattias","family":"Carlstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"429_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration.","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","volume":"2","author":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.","year":"2014","unstructured":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2, 634\u2013647 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jash.2014.07.003","volume":"8","author":"A Whaley-Connell","year":"2014","unstructured":"Whaley-Connell, A. & Sowers, J. R. Basic science: pathophysiology: the cardiorenal metabolic syndrome. J. Am. Soc. Hypertens. 8, 604\u2013606 (2014).","journal-title":"J. Am. Soc. Hypertens."},{"key":"429_CR4","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami, J. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139, e840\u2013e878 (2019).","journal-title":"Circulation"},{"key":"429_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2015.191","volume":"12","author":"J Aron-Wisnewsky","year":"2016","unstructured":"Aron-Wisnewsky, J. & Clement, K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat. Rev. Nephrol. 12, 169\u2013181 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"T Yang","year":"2018","unstructured":"Yang, T., Richards, E. M., Pepine, C. J. & Raizada, M. K. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat. Rev. Nephrol. 14, 442\u2013456 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR7","doi-asserted-by":"publisher","first-page":"165811","DOI":"10.1016\/j.bbadis.2020.165811","volume":"1866","author":"TA Schiffer","year":"2020","unstructured":"Schiffer, T. A., Lundberg, J. O., Weitzberg, E. & Carlstrom, M. Modulation of mitochondria and NADPH oxidase function by the nitrate-nitrite-NO pathway in metabolic disease with focus on type 2 diabetes. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165811 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"429_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12818","volume":"285","author":"M Carlstrom","year":"2019","unstructured":"Carlstrom, M. & Montenegro, M. F. Therapeutic value of stimulating the nitrate-nitrite-nitric oxide pathway to attenuate oxidative stress and restore nitric oxide bioavailability in cardiorenal disease. J. Intern. Med. 285, 2\u201318 (2019).","journal-title":"J. Intern. Med."},{"key":"429_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd4623","volume":"14","author":"JO Lundberg","year":"2015","unstructured":"Lundberg, J. O., Gladwin, M. T. & Weitzberg, E. Strategies to increase nitric oxide signalling in cardiovascular disease. Nat. Rev. Drug Discov. 14, 623\u2013641 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"429_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physrev.00036.2017","volume":"99","author":"J Tejero","year":"2019","unstructured":"Tejero, J., Shiva, S. & Gladwin, M. T. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol. Rev. 99, 311\u2013379 (2019).","journal-title":"Physiol. Rev."},{"key":"429_CR11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/gut.35.11.1543","volume":"35","author":"JO Lundberg","year":"1994","unstructured":"Lundberg, J. O., Weitzberg, E., Lundberg, J. M. & Alving, K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35, 1543\u20131546 (1994).","journal-title":"Gut"},{"key":"429_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/368502a0","volume":"368","author":"N Benjamin","year":"1994","unstructured":"Benjamin, N. et al. Stomach NO synthesis. Nature 368, 502 (1994).","journal-title":"Nature"},{"key":"429_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm0895-804","volume":"1","author":"JL Zweier","year":"1995","unstructured":"Zweier, J. L., Wang, P., Samouilov, A. & Kuppusamy, P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1, 804\u2013809 (1995).","journal-title":"Nat. Med."},{"key":"429_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/351714a0","volume":"351","author":"DS Bredt","year":"1991","unstructured":"Bredt, D. S. et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714\u2013718 (1991).","journal-title":"Nature"},{"key":"429_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-5793(92)80697-F","volume":"307","author":"PA Marsden","year":"1992","unstructured":"Marsden, P. A. et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 307, 287\u2013293 (1992).","journal-title":"FEBS Lett."},{"key":"429_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.1373522","volume":"256","author":"QW Xie","year":"1992","unstructured":"Xie, Q. W. et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225\u2013228 (1992).","journal-title":"Science"},{"key":"429_CR17","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1016\/S0021-9258(17)37441-0","volume":"269","author":"NA Chartrain","year":"1994","unstructured":"Chartrain, N. A. et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269, 6765\u20136772 (1994).","journal-title":"J. Biol. Chem."},{"key":"429_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U Forstermann","year":"2012","unstructured":"Forstermann, U. & Sessa, W. C. Nitric oxide synthases: regulation and function. Eur. Heart J. 33, 829\u2013837 (2012).","journal-title":"Eur. Heart J."},{"key":"429_CR19","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109\u2013142 (1991).","journal-title":"Pharmacol. Rev."},{"key":"429_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/bph.12980","volume":"172","author":"A Papapetropoulos","year":"2015","unstructured":"Papapetropoulos, A., Hobbs, A. J. & Topouzis, S. Extending the translational potential of targeting NO\/cGMP-regulated pathways in the CVS. Br. J. Pharmacol. 172, 1397\u20131414 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"429_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/CIRCRESAHA.109.207381","volume":"106","author":"B Lima","year":"2010","unstructured":"Lima, B., Forrester, M. T., Hess, D. T. & Stamler, J. S. S-nitrosylation in cardiovascular signaling. Circ. Res. 106, 633\u2013646 (2010).","journal-title":"Circ. Res."},{"key":"429_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.abb.2008.10.034","volume":"484","author":"H Ischiropoulos","year":"2009","unstructured":"Ischiropoulos, H. Protein tyrosine nitration \u2014 an update. Arch. Biochem. Biophys. 484, 117\u2013121 (2009).","journal-title":"Arch. Biochem. Biophys."},{"key":"429_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2741\/4425","volume":"21","author":"L Villacorta","year":"2016","unstructured":"Villacorta, L., Gao, Z., Schopfer, F. J., Freeman, B. A. & Chen, Y. E. Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms. Front. Biosci. 21, 873\u2013889 (2016).","journal-title":"Front. Biosci."},{"key":"429_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.freeradbiomed.2017.08.025","volume":"112","author":"AL Kleschyov","year":"2017","unstructured":"Kleschyov, A. L. The NO-heme signaling hypothesis. Free Radic. Biol. Med. 112, 544\u2013552 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(92)90386-I","volume":"211","author":"YP Vedernikov","year":"1992","unstructured":"Vedernikov, Y. P., Mordvintcev, P. I., Malenkova, I. V. & Vanin, A. F. Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor. Eur. J. Pharmacol. 211, 313\u2013317 (1992).","journal-title":"Eur. J. Pharmacol."},{"key":"429_CR26","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1126\/science.1281928","volume":"258","author":"JS Stamler","year":"1992","unstructured":"Stamler, J. S., Singel, D. J. & Loscalzo, J. Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898\u20131902 (1992).","journal-title":"Science"},{"key":"429_CR27","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1074\/jbc.REV119.006136","volume":"294","author":"MN Moller","year":"2019","unstructured":"Moller, M. N. et al. Detection and quantification of nitric oxide-derived oxidants in biological systems. J. Biol. Chem. 294, 14776\u201314802 (2019).","journal-title":"J. Biol. Chem."},{"key":"429_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.freeradbiomed.2016.09.005","volume":"99","author":"C Bolden","year":"2016","unstructured":"Bolden, C., King, S. B. & Kim-Shapiro, D. B. Reactions between nitrosopersulfide and heme proteins. Free Radic. Biol. Med. 99, 418\u2013425 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR29","doi-asserted-by":"publisher","first-page":"10860","DOI":"10.1073\/pnas.88.23.10860","volume":"88","author":"ME Murphy","year":"1991","unstructured":"Murphy, M. E. & Sies, H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc. Natl Acad. Sci. USA 88, 10860\u201310864 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","volume":"87","author":"JS Beckman","year":"1990","unstructured":"Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA 87, 1620\u20131624 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR31","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.2174\/13816128113196660745","volume":"20","author":"EH Heiss","year":"2014","unstructured":"Heiss, E. H. & Dirsch, V. M. Regulation of eNOS enzyme activity by posttranslational modification. Curr. Pharm. Des. 20, 3503\u20133513 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"429_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14728222.2017.1265505","volume":"21","author":"NM Sharma","year":"2017","unstructured":"Sharma, N. M. & Patel, K. P. Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states. Expert Opin. Ther. Targets 21, 11\u201322 (2017).","journal-title":"Expert Opin. Ther. Targets"},{"key":"429_CR33","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1074\/jbc.R111.285742","volume":"287","author":"DT Hess","year":"2012","unstructured":"Hess, D. T. & Stamler, J. S. Regulation by S-nitrosylation of protein post-translational modification. J. Biol. Chem. 287, 4411\u20134418 (2012).","journal-title":"J. Biol. Chem."},{"key":"429_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.yjmcc.2006.05.023","volume":"42","author":"PF Mount","year":"2007","unstructured":"Mount, P. F., Kemp, B. E. & Power, D. A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 42, 271\u2013279 (2007).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"429_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1748-1716.2006.01582.x","volume":"187","author":"PF Mount","year":"2006","unstructured":"Mount, P. F. & Power, D. A. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol. 187, 433\u2013446 (2006).","journal-title":"Acta Physiol."},{"key":"429_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF03401781","volume":"6","author":"R Zamora","year":"2000","unstructured":"Zamora, R., Vodovotz, Y. & Billiar, T. R. Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 6, 347\u2013373 (2000).","journal-title":"Mol. Med."},{"key":"429_CR37","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","volume":"294","author":"C Baylis","year":"2008","unstructured":"Baylis, C. Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Renal Physiol. 294, F1\u2013F9 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncpneph0143","volume":"2","author":"C Baylis","year":"2006","unstructured":"Baylis, C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat. Clin. Pract. Nephrol. 2, 209\u2013220 (2006).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"429_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah, C., Michel, L. Y. M. & Balligand, J. L. Nitric oxide signalling in cardiovascular health and disease. Nat. Rev. Cardiol. 15, 292\u2013316 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"429_CR40","doi-asserted-by":"publisher","first-page":"27184","DOI":"10.1074\/jbc.271.43.27184","volume":"271","author":"NT Eissa","year":"1996","unstructured":"Eissa, N. T. et al. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J. Biol. Chem. 271, 27184\u201327187 (1996).","journal-title":"J. Biol. Chem."},{"key":"429_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0016-5085(00)70171-5","volume":"118","author":"D Saur","year":"2000","unstructured":"Saur, D., Paehge, H., Schusdziarra, V. & Allescher, H. D. Distinct expression of splice variants of neuronal nitric oxide synthase in the human gastrointestinal tract. Gastroenterology 118, 849\u2013858 (2000).","journal-title":"Gastroenterology"},{"key":"429_CR42","doi-asserted-by":"publisher","first-page":"F1465","DOI":"10.1152\/ajprenal.00650.2009","volume":"298","author":"D Lu","year":"2010","unstructured":"Lu, D. et al. Salt sensitive splice variant of nNOS expressed in the macula densa cells. Am. J. Physiol. Renal Physiol. 298, F1465\u2013F1471 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1523-1755.2003.00078.x","volume":"64","author":"A Jarry","year":"2003","unstructured":"Jarry, A. et al. Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine\/paracrine action of nitric oxide. Kidney Int. 64, 170\u2013180 (2003).","journal-title":"Kidney Int."},{"key":"429_CR44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1523-1755.2002.00233.x","volume":"61","author":"MS Goligorsky","year":"2002","unstructured":"Goligorsky, M. S., Brodsky, S. V. & Noiri, E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 61, 855\u2013861 (2002).","journal-title":"Kidney Int."},{"key":"429_CR45","doi-asserted-by":"publisher","first-page":"F62","DOI":"10.1152\/ajprenal.00234.2009","volume":"298","author":"KH Yoo","year":"2010","unstructured":"Yoo, K. H., Thornhill, B. A., Forbes, M. S. & Chevalier, R. L. Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. Am. J. Physiol. Renal Physiol. 298, F62\u2013F71 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2215\/CJN.00490206","volume":"1","author":"S Heemskerk","year":"2006","unstructured":"Heemskerk, S. et al. Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin. J. Am. Soc. Nephrol. 1, 853\u2013862 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"429_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/bph.14849","volume":"177","author":"S Udi","year":"2020","unstructured":"Udi, S. et al. Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease. Br. J. Pharmacol. 177, 110\u2013127 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"429_CR48","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/ndt\/gfl444","volume":"21","author":"P Bautista-Garcia","year":"2006","unstructured":"Bautista-Garcia, P. et al. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5\/6 nephrectomized rats. Nephrol. Dial. Transpl. 21, 3074\u20133081 (2006).","journal-title":"Nephrol. Dial. Transpl."},{"key":"429_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0005-2728(99)00020-1","volume":"1411","author":"M Kelm","year":"1999","unstructured":"Kelm, M. Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta 1411, 273\u2013289 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"429_CR50","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.107.712133","volume":"116","author":"A Dejam","year":"2007","unstructured":"Dejam, A. et al. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116, 1821\u20131831 (2007).","journal-title":"Circulation"},{"key":"429_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrd2466","volume":"7","author":"JO Lundberg","year":"2008","unstructured":"Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156\u2013167 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"429_CR52","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1006\/bbrc.1995.1541","volume":"209","author":"P Rhodes","year":"1995","unstructured":"Rhodes, P. et al. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 209, 590\u2013596 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"429_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2004.04.027","volume":"37","author":"JO Lundberg","year":"2004","unstructured":"Lundberg, J. O. & Govoni, M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med. 37, 395\u2013400 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR54","doi-asserted-by":"publisher","first-page":"13434","DOI":"10.1073\/pnas.1116633109","volume":"109","author":"L Qin","year":"2012","unstructured":"Qin, L. et al. Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane. Proc. Natl Acad. Sci. USA 109, 13434\u201313439 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR55","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(54)91196-4","volume":"266","author":"DA Edwards","year":"1954","unstructured":"Edwards, D. A., Fletcher, K. & Rowlands, E. N. Antagonism between perchlorate, iodide, thiocyanate, and nitrate for secretion in human saliva; analogy with the iodide trap of the thyroid. Lancet 266, 498\u2013499 (1954).","journal-title":"Lancet"},{"key":"429_CR56","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nm0695-546","volume":"1","author":"C Duncan","year":"1995","unstructured":"Duncan, C. et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat. Med. 1, 546\u2013551 (1995).","journal-title":"Nat. Med."},{"key":"429_CR57","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2011-301649","volume":"62","author":"JO Lundberg","year":"2013","unstructured":"Lundberg, J. O. & Weitzberg, E. Biology of nitrogen oxides in the gastrointestinal tract. Gut 62, 616\u2013629 (2013).","journal-title":"Gut"},{"key":"429_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/hsz-2016-0263","volume":"398","author":"CC Helms","year":"2016","unstructured":"Helms, C. C., Liu, X. & Kim-Shapiro, D. B. Recent insights into nitrite signaling processes in blood. Biol. Chem. 398, 319\u2013329 (2016).","journal-title":"Biol. Chem."},{"key":"429_CR59","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.2174\/1568026617666161116145046","volume":"17","author":"AB Blood","year":"2017","unstructured":"Blood, A. B. The medicinal chemistry of nitrite as a source of nitric oxide signaling. Curr. Top. Med. Chem. 17, 1758\u20131768 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"429_CR60","doi-asserted-by":"publisher","first-page":"13683","DOI":"10.1073\/pnas.0402927101","volume":"101","author":"A Webb","year":"2004","unstructured":"Webb, A. et al. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc. Natl Acad. Sci. USA 101, 13683\u201313688 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR61","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.bbrc.2006.01.031","volume":"341","author":"C Gautier","year":"2006","unstructured":"Gautier, C., van Faassen, E., Mikula, I., Martasek, P. & Slama-Schwok, A. Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem. Biophys. Res. Commun. 341, 816\u2013821 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"429_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cmet.2006.02.011","volume":"3","author":"PR Castello","year":"2006","unstructured":"Castello, P. R., David, P. S., McClure, T., Crook, Z. & Poyton, R. O. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab. 3, 277\u2013287 (2006).","journal-title":"Cell Metab."},{"key":"429_CR63","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/med.20151","volume":"29","author":"EE van Faassen","year":"2009","unstructured":"van Faassen, E. E. et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 29, 683\u2013741 (2009).","journal-title":"Med. Res. Rev."},{"key":"429_CR64","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1182\/blood-2005-07-2668","volume":"107","author":"JH Crawford","year":"2006","unstructured":"Crawford, J. H. et al. Hypoxia, red blood cells, and nitrite regulate NO\u2212dependent hypoxic vasodilation. Blood 107, 566\u2013574 (2006).","journal-title":"Blood"},{"key":"429_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1152\/physrev.00042.2012","volume":"95","author":"M Carlstrom","year":"2015","unstructured":"Carlstrom, M., Wilcox, C. S. & Arendshorst, W. J. Renal autoregulation in health and disease. Physiol. Rev. 95, 405\u2013511 (2015).","journal-title":"Physiol. Rev."},{"key":"429_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphys.2013.00187","volume":"4","author":"AE Persson","year":"2013","unstructured":"Persson, A. E., Lai, E. Y., Gao, X., Carlstrom, M. & Patzak, A. Interactions between adenosine, angiotensin II and nitric oxide on the afferent arteriole influence sensitivity of the tubuloglomerular feedback. Front. Physiol. 4, 187 (2013).","journal-title":"Front. Physiol."},{"key":"429_CR67","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/cphy.c100043","volume":"1","author":"EJ Johns","year":"2011","unstructured":"Johns, E. J., Kopp, U. C. & DiBona, G. F. Neural control of renal function. Compr. Physiol. 1, 731\u2013767 (2011).","journal-title":"Compr. Physiol."},{"key":"429_CR68","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1113\/jphysiol.2005.094888","volume":"569","author":"A Just","year":"2005","unstructured":"Just, A. & Arendshorst, W. J. Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback. J. Physiol. 569, 959\u2013974 (2005).","journal-title":"J. Physiol."},{"key":"429_CR69","doi-asserted-by":"publisher","first-page":"R982","DOI":"10.1152\/ajpregu.00346.2005","volume":"290","author":"Y Shi","year":"2006","unstructured":"Shi, Y., Wang, X., Chon, K. H. & Cupples, W. A. Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R982\u2013R991 (2006).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"429_CR70","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.111.170472","volume":"58","author":"EY Lai","year":"2011","unstructured":"Lai, E. Y., Wellstein, A., Welch, W. J. & Wilcox, C. S. Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension 58, 650\u2013656 (2011).","journal-title":"Hypertension"},{"key":"429_CR71","first-page":"F113","volume":"277","author":"A Ichihara","year":"1999","unstructured":"Ichihara, A. & Navar, L. G. Neuronal NOS contributes to biphasic autoregulatory response during enhanced TGF activity. Am. J. Physiol. 277, F113\u2212F120 (1999).","journal-title":"Am. J. Physiol."},{"key":"429_CR72","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1124\/pr.110.002907","volume":"62","author":"SH Francis","year":"2010","unstructured":"Francis, S. H., Busch, J. L., Corbin, J. D. & Sibley, D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 62, 525\u2013563 (2010).","journal-title":"Pharmacol. Rev."},{"key":"429_CR73","first-page":"R1362","volume":"281","author":"R Brown","year":"2001","unstructured":"Brown, R. et al. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1362\u20131367 (2001).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"429_CR74","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1073\/pnas.171317998","volume":"98","author":"D Sun","year":"2001","unstructured":"Sun, D. et al. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl Acad. Sci. USA 98, 9983\u20139988 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR75","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1172\/JCI18499","volume":"112","author":"EW Inscho","year":"2003","unstructured":"Inscho, E. W., Cook, A. K., Imig, J. D., Vial, C. & Evans, R. J. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J. Clin. Invest. 112, 1895\u20131905 (2003).","journal-title":"J. Clin. Invest."},{"key":"429_CR76","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/01.ASN.0000014827.71910.39","volume":"13","author":"R Liu","year":"2002","unstructured":"Liu, R. et al. Purinergic receptor signaling at the basolateral membrane of macula densa cells. J. Am. Soc. Nephrol. 13, 1145\u20131151 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0008-6363(02)00536-9","volume":"56","author":"A Ollerstam","year":"2002","unstructured":"Ollerstam, A. & Persson, A. E. Macula densa neuronal nitric oxide synthase. Cardiovasc. Res. 56, 189\u2013196 (2002).","journal-title":"Cardiovasc. Res."},{"key":"429_CR78","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.1073\/pnas.89.24.11993","volume":"89","author":"CS Wilcox","year":"1992","unstructured":"Wilcox, C. S. et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc. Natl Acad. Sci. USA 89, 11993\u201311997 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR79","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1523-1755.2005.00282.x","volume":"67","author":"R Liu","year":"2005","unstructured":"Liu, R., Carretero, O. A., Ren, Y. & Garvin, J. L. Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback. Kidney Int. 67, 1837\u20131843 (2005).","journal-title":"Kidney Int."},{"key":"429_CR80","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1681\/ASN.V1281599","volume":"12","author":"V Vallon","year":"2001","unstructured":"Vallon, V. et al. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J. Am. Soc. Nephrol. 12, 1599\u20131606 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR81","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00795-006-0310-2","volume":"39","author":"A Tojo","year":"2006","unstructured":"Tojo, A., Onozato, M. L. & Fujita, T. Role of macula densa neuronal nitric oxide synthase in renal diseases. Med. Mol. Morphol. 39, 2\u20137 (2006).","journal-title":"Med. Mol. Morphol."},{"key":"429_CR82","first-page":"F246","volume":"271","author":"C Thorup","year":"1996","unstructured":"Thorup, C. & Persson, A. E. Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rats. Am. J. Physiol. 271, F246\u2013F252 (1996).","journal-title":"Am. J. Physiol."},{"key":"429_CR83","doi-asserted-by":"publisher","first-page":"F769","DOI":"10.1152\/ajprenal.2000.278.5.F769","volume":"278","author":"WJ Welch","year":"2000","unstructured":"Welch, W. J., Tojo, A. & Wilcox, C. S. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am. J. Physiol. Renal Physiol. 278, F769\u2013776 (2000).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR84","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1172\/JCI119394","volume":"99","author":"A Ollerstam","year":"1997","unstructured":"Ollerstam, A., Pittner, J., Persson, A. E. & Thorup, C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J. Clin. Invest. 99, 2212\u20132218 (1997).","journal-title":"J. Clin. Invest."},{"key":"429_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000052608","volume":"9","author":"TL Pallone","year":"2001","unstructured":"Pallone, T. L. & Silldorff, E. P. Pericyte regulation of renal medullary blood flow. Exp. Nephrol. 9, 165\u2013170 (2001).","journal-title":"Exp. Nephrol."},{"key":"429_CR86","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/apha.12084","volume":"208","author":"MM Sendeski","year":"2013","unstructured":"Sendeski, M. M. et al. Functional characterization of isolated, perfused outermedullary descending human vasa recta. Acta Physiol. 208, 50\u201356 (2013).","journal-title":"Acta Physiol."},{"key":"429_CR87","doi-asserted-by":"publisher","first-page":"F1056","DOI":"10.1152\/ajprenal.00070.2010","volume":"299","author":"C Cao","year":"2010","unstructured":"Cao, C. et al. Intrinsic nitric oxide and superoxide production regulates descending vasa recta contraction. Am. J. Physiol. Renal Physiol. 299, F1056\u2013F1064 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR88","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1523-1755.2005.00073.x","volume":"67","author":"J Pittner","year":"2005","unstructured":"Pittner, J., Wolgast, M., Casellas, D. & Persson, A. E. Increased shear stress-released NO and decreased endothelial calcium in rat isolated perfused juxtamedullary nephrons. Kidney Int. 67, 227\u2013236 (2005).","journal-title":"Kidney Int."},{"key":"429_CR89","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/01.HYP.19.6.770","volume":"19","author":"JD Imig","year":"1992","unstructured":"Imig, J. D. & Roman, R. J. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 19, 770\u2013774 (1992).","journal-title":"Hypertension"},{"key":"429_CR90","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-physiol-012110-142247","volume":"73","author":"JL Garvin","year":"2010","unstructured":"Garvin, J. L., Herrera, M. & Ortiz, P. A. Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: clinical implications. Annu. Rev. Physiol. 73, 359\u2013376 (2010).","journal-title":"Annu. Rev. Physiol."},{"key":"429_CR91","doi-asserted-by":"publisher","first-page":"F777","DOI":"10.1152\/ajprenal.00334.2001","volume":"282","author":"PA Ortiz","year":"2002","unstructured":"Ortiz, P. A. & Garvin, J. L. Role of nitric oxide in the regulation of nephron transport. Am. J. Physiol. Renal Physiol. 282, F777\u2013F784 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR92","doi-asserted-by":"publisher","first-page":"6871081","DOI":"10.1155\/2017\/6871081","volume":"2017","author":"N Satoh","year":"2017","unstructured":"Satoh, N. et al. Effects of nitric oxide on renal proximal tubular Na+ transport. BioMed. Res. Int. 2017, 6871081 (2017).","journal-title":"BioMed. Res. Int."},{"key":"429_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13443","volume":"229","author":"Z Bahadoran","year":"2020","unstructured":"Bahadoran, Z., Carlstrom, M., Mirmiran, P. & Ghasemi, A. Nitric oxide: to be or not to be an endocrine hormone? Acta Physiol. 229, e13443 (2020).","journal-title":"Acta Physiol."},{"key":"429_CR94","unstructured":"Boron, W. F. & Boulpaep, E. L. Medical Physiology, a Cellular and Molecular Approach 3rd edn (Elsevier, 2016)."},{"key":"429_CR95","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-physiol-012110-142247","volume":"73","author":"JL Garvin","year":"2011","unstructured":"Garvin, J. L., Herrera, M. & Ortiz, P. A. Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: clinical implications. Annu. Rev. Physiol. 73, 359\u2013376 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"429_CR96","doi-asserted-by":"crossref","first-page":"F870","DOI":"10.1152\/ajpcell.1998.275.3.C870","volume":"275","author":"A Broere","year":"1998","unstructured":"Broere, A. et al. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME. Am. J. Physiol. 275, F870\u2013F877 (1998).","journal-title":"Am. J. Physiol."},{"key":"429_CR97","first-page":"F845","volume":"270","author":"JN Bech","year":"1996","unstructured":"Bech, J. N., Nielsen, C. B. & Pedersen, E. B. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans. Am. J. Physiol. 270, F845\u2013F851 (1996).","journal-title":"Am. J. Physiol."},{"key":"429_CR98","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1681\/ASN.2013060596","volume":"25","author":"A Shirai","year":"2014","unstructured":"Shirai, A. et al. Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide\/guanosine 3\u2032,5\u2032-cyclic monophosphate pathway. J. Am. Soc. Nephrol. 25, 1523\u20131532 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/HYPERTENSIONAHA.113.01291","volume":"62","author":"KA Hyndman","year":"2013","unstructured":"Hyndman, K. A. et al. Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure. Hypertension 62, 91\u201398 (2013).","journal-title":"Hypertension"},{"key":"429_CR100","first-page":"1921","volume":"43","author":"DA Wagner","year":"1983","unstructured":"Wagner, D. A., Schultz, D. S., Deen, W. M., Young, V. R. & Tannenbaum, S. R. Metabolic fate of an oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Res. 43, 1921\u20131925 (1983).","journal-title":"Cancer Res."},{"key":"429_CR101","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1073\/pnas.78.12.7764","volume":"78","author":"LC Green","year":"1981","unstructured":"Green, L. C. et al. Nitrate biosynthesis in man. Proc. Natl Acad. Sci. USA 78, 7764\u20137768 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR102","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.niox.2020.01.011","volume":"97","author":"JK Williams","year":"2020","unstructured":"Williams, J. K. et al. Renal nitrate clearance in chronic kidney disease. Nitric Oxide 97, 16\u201319 (2020).","journal-title":"Nitric Oxide"},{"key":"429_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13637","author":"ML Sundqvist","year":"2021","unstructured":"Sundqvist, M. L., Lundberg, J. O., Weitzberg, E. & Carlstrom, M. Renal handling of nitrate in women and men with elevated blood pressure. Acta Physiol. https:\/\/doi.org\/10.1111\/apha.13637 (2021).","journal-title":"Acta Physiol."},{"key":"429_CR104","doi-asserted-by":"crossref","first-page":"F68","DOI":"10.1152\/ajpcell.1998.275.1.C68","volume":"275","author":"M Godfrey","year":"1998","unstructured":"Godfrey, M. & Majid, D. S. Renal handling of circulating nitrates in anesthetized dogs. Am. J. Physiol. 275, F68\u2013F73 (1998).","journal-title":"Am. J. Physiol."},{"key":"429_CR105","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ki.1995.411","volume":"48","author":"T Suto","year":"1995","unstructured":"Suto, T. et al. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int. 48, 1272\u20131277 (1995).","journal-title":"Kidney Int."},{"key":"429_CR106","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.niox.2012.01.005","volume":"26","author":"K Chobanyan-Jurgens","year":"2012","unstructured":"Chobanyan-Jurgens, K. et al. Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 26, 126\u2013131 (2012).","journal-title":"Nitric Oxide"},{"key":"429_CR107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-2999(01)01357-7","volume":"428","author":"M Rahma","year":"2001","unstructured":"Rahma, M. et al. Effects of furosemide on the tubular reabsorption of nitrates in anesthetized dogs. Eur. J. Pharmacol. 428, 113\u2013119 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"429_CR108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-physiol-021014-071854","volume":"77","author":"SM Wall","year":"2015","unstructured":"Wall, S. M. & Lazo-Fernandez, Y. The role of pendrin in renal physiology. Annu. Rev. Physiol. 77, 363\u2013378 (2015).","journal-title":"Annu. Rev. Physiol."},{"key":"429_CR109","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00577.2011","volume":"303","author":"M Thumova","year":"2012","unstructured":"Thumova, M. et al. Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMP. Am. J. Physiol. Renal Physiol. 303, F812\u2013F820 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR110","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.nbd.2004.12.020","volume":"19","author":"N Yarovaya","year":"2005","unstructured":"Yarovaya, N. et al. Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated. Neurobiol. Dis. 19, 351\u2013365 (2005).","journal-title":"Neurobiol. Dis."},{"key":"429_CR111","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","volume":"11","author":"F Jiang","year":"2014","unstructured":"Jiang, F. et al. Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets. Nat. Rev. Cardiol. 11, 413\u2013426 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"429_CR112","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.freeradbiomed.2019.11.029","volume":"152","author":"M Barnes","year":"2020","unstructured":"Barnes, M. & Brisbois, E. J. Clinical use of inhaled nitric oxide: local and systemic applications. Free Radic. Biol. Med. 152, 422\u2013431 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0880-2","volume":"19","author":"SY Ruan","year":"2015","unstructured":"Ruan, S. Y. et al. Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trials. Crit. Care 19, 137 (2015).","journal-title":"Crit. Care"},{"key":"429_CR114","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/ars.2015.6376","volume":"23","author":"A Daiber","year":"2015","unstructured":"Daiber, A. & Munzel, T. Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress. Antioxid. Redox Signal. 23, 899\u2013942 (2015).","journal-title":"Antioxid. Redox Signal."},{"key":"429_CR115","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","volume":"30","author":"C Antoniades","year":"2009","unstructured":"Antoniades, C. et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur. Heart J. 30, 1142\u20131150 (2009).","journal-title":"Eur. Heart J."},{"key":"429_CR116","doi-asserted-by":"publisher","first-page":"15049","DOI":"10.1073\/pnas.1307058110","volume":"110","author":"J Yang","year":"2013","unstructured":"Yang, J., Gonon, A. T., Sjoquist, P. O., Lundberg, J. O. & Pernow, J. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proc. Natl Acad. Sci. USA 110, 15049\u201315054 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR117","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.niox.2018.06.004","volume":"78","author":"X Liu","year":"2018","unstructured":"Liu, X., Xu, X., Shang, R. & Chen, Y. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease. Nitric Oxide 78, 113\u2013120 (2018).","journal-title":"Nitric Oxide"},{"key":"429_CR118","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P. & Caldwell, R. B. Arginase: a multifaceted enzyme important in health and disease. Physiol. Rev. 98, 641\u2013665 (2018).","journal-title":"Physiol. Rev."},{"key":"429_CR119","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1210\/jc.2016-2007","volume":"101","author":"O Kovamees","year":"2016","unstructured":"Kovamees, O. et al. Arginase inhibition improves microvascular endothelial function in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 101, 3952\u20133958 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"429_CR120","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.112.140335","volume":"126","author":"A Shemyakin","year":"2012","unstructured":"Shemyakin, A. et al. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 126, 2943\u20132950 (2012).","journal-title":"Circulation"},{"key":"429_CR121","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1113\/jphysiol.2014.275263","volume":"592","author":"T Ashmore","year":"2014","unstructured":"Ashmore, T. et al. Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart. J. Physiol. 592, 4715\u20134731 (2014).","journal-title":"J. Physiol."},{"key":"429_CR122","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cvr\/cvt036","volume":"98","author":"J Pernow","year":"2013","unstructured":"Pernow, J. & Jung, C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc. Res. 98, 334\u2013343 (2013).","journal-title":"Cardiovasc. Res."},{"key":"429_CR123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/ars.2011.4451","volume":"17","author":"C Szabo","year":"2012","unstructured":"Szabo, C. Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox Signal. 17, 68\u201380 (2012).","journal-title":"Antioxid. Redox Signal."},{"key":"429_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.12.005","volume":"149","author":"BS Kasinath","year":"2018","unstructured":"Kasinath, B. S., Feliers, D. & Lee, H. J. Hydrogen sulfide as a regulatory factor in kidney health and disease. Biochem. Pharmacol. 149, 29\u201341 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"429_CR125","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/CIRCRESAHA.118.311134","volume":"123","author":"Z Li","year":"2018","unstructured":"Li, Z., Polhemus, D. J. & Lefer, D. J. Evolution of hydrogen sulfide therapeutics to treat cardiovascular disease. Circ. Res. 123, 590\u2013600 (2018).","journal-title":"Circ. Res."},{"key":"429_CR126","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jcmm.12077","volume":"17","author":"Z Altaany","year":"2013","unstructured":"Altaany, Z., Yang, G. & Wang, R. Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells. J. Cell Mol. Med. 17, 879\u2013888 (2013).","journal-title":"J. Cell Mol. Med."},{"key":"429_CR127","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1073\/pnas.1202916109","volume":"109","author":"C Coletta","year":"2012","unstructured":"Coletta, C. et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc. Natl Acad. Sci. USA 109, 9161\u20139166 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR128","doi-asserted-by":"publisher","first-page":"101447","DOI":"10.1016\/j.redox.2020.101447","volume":"34","author":"S Pardue","year":"2020","unstructured":"Pardue, S. et al. Hydrogen sulfide stimulates xanthine oxidoreductase conversion to nitrite reductase and formation of NO. Redox Biol. 34, 101447 (2020).","journal-title":"Redox Biol."},{"key":"429_CR129","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","volume":"30","author":"M Bucci","year":"2010","unstructured":"Bucci, M. et al. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler. Thromb. Vasc. Biol. 30, 1998\u20132004 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"429_CR130","doi-asserted-by":"publisher","first-page":"E4651","DOI":"10.1073\/pnas.1509277112","volume":"112","author":"MM Cortese-Krott","year":"2015","unstructured":"Cortese-Krott, M. M. et al. Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl. Proc. Natl Acad. Sci. USA 112, E4651\u2013E4660 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR131","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2011.09.086","volume":"59","author":"RC Kukreja","year":"2012","unstructured":"Kukreja, R. C., Salloum, F. N. & Das, A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J. Am. Coll. Cardiol. 59, 1921\u20131927 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"429_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.113.01774","volume":"63","author":"KE Brown","year":"2014","unstructured":"Brown, K. E., Dhaun, N., Goddard, J. & Webb, D. J. Potential therapeutic role of phosphodiesterase type 5 inhibition in hypertension and chronic kidney disease. Hypertension 63, 5\u201311 (2014).","journal-title":"Hypertension"},{"key":"429_CR133","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1111\/j.1523-1755.2005.00669.x","volume":"68","author":"B Rodriguez-Iturbe","year":"2005","unstructured":"Rodriguez-Iturbe, B. et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int. 68, 2131\u20132142 (2005).","journal-title":"Kidney Int."},{"key":"429_CR134","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1111\/bph.14205","volume":"175","author":"KE Andersson","year":"2018","unstructured":"Andersson, K. E. PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br. J. Pharmacol. 175, 2554\u20132565 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"429_CR135","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1681\/ASN.2015050473","volume":"27","author":"W Scheele","year":"2016","unstructured":"Scheele, W. et al. Phosphodiesterase type 5 inhibition reduces albuminuria in subjects with overt diabetic nephropathy. J. Am. Soc. Nephrol. 27, 3459\u20133468 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR136","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.niox.2018.05.009","volume":"78","author":"ES Buys","year":"2018","unstructured":"Buys, E. S. et al. Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential. Nitric Oxide 78, 72\u201380 (2018).","journal-title":"Nitric Oxide"},{"key":"429_CR137","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/164_2018_197","volume":"264","author":"P Sandner","year":"2019","unstructured":"Sandner, P. et al. Soluble guanylate cyclase stimulators and activators. Handb. Exp. Pharmacol. 264, 355\u2013394 (2019).","journal-title":"Handb. Exp. Pharmacol."},{"key":"429_CR138","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","volume":"38","author":"B Pieske","year":"2017","unstructured":"Pieske, B. et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the soluble guanylate cyclase stimulator in heart failure patients with preserved EF (SOCRATES-PRESERVED) study. Eur. Heart J. 38, 1119\u20131127 (2017).","journal-title":"Eur. Heart J."},{"key":"429_CR139","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong, P. W. et al. Vericiguat in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 382, 1883\u20131893 (2020).","journal-title":"N. Engl. J. Med."},{"key":"429_CR140","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coph.2014.12.014","volume":"21","author":"JP Stasch","year":"2015","unstructured":"Stasch, J. P., Schlossmann, J. & Hocher, B. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence. Curr. Opin. Pharmacol. 21, 95\u2013104 (2015).","journal-title":"Curr. Opin. Pharmacol."},{"key":"429_CR141","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/2211-5463.12202","volume":"7","author":"E Schinner","year":"2017","unstructured":"Schinner, E. et al. Inhibition of the TGFbeta signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis. FEBS Open Bio. 7, 550\u2013561 (2017).","journal-title":"FEBS Open Bio."},{"key":"429_CR142","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2215\/CJN.08410520","volume":"16","author":"JP Hanrahan","year":"2020","unstructured":"Hanrahan, J. P. et al. Effects of the soluble guanylate cyclase stimulator praliciguat in diabetic kidney disease: a randomized placebo-controlled clinical trial. Clin. J. Am. Soc. Nephrol. 16, 59\u201369 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"429_CR143","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20110677","volume":"123","author":"M Horiuchi","year":"2012","unstructured":"Horiuchi, M., Iwanami, J. & Mogi, M. Regulation of angiotensin II receptors beyond the classical pathway. Clin. Sci. 123, 193\u2013203 (2012).","journal-title":"Clin. Sci."},{"key":"429_CR144","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2012.249","volume":"9","author":"B Seva Pessoa","year":"2013","unstructured":"Seva Pessoa, B. et al. Key developments in renin-angiotensin-aldosterone system inhibition. Nat. Rev. Nephrol. 9, 26\u201336 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","volume":"107","author":"S Bae","year":"2021","unstructured":"Bae, S., Kim, S. R., Kim, M. N., Shim, W. J. & Park, S. M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart 107, 373\u2013380 (2021).","journal-title":"Heart"},{"key":"429_CR146","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","volume":"36","author":"E-E Council","year":"2021","unstructured":"Council, E.-E. & Group, E. W. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol. Dial. Transpl. 36, 87\u201394 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"429_CR147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","volume":"17","author":"S Lim","year":"2021","unstructured":"Lim, S., Bae, J. H., Kwon, H. S. & Nauck, M. A. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 17, 11\u201330 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"429_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03120-0","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni, W. et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care 24, 422 (2020).","journal-title":"Crit. Care"},{"key":"429_CR149","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","volume":"17","author":"L Perico","year":"2021","unstructured":"Perico, L. et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 17, 46\u201364 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR150","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2020.12.008","volume":"163","author":"W Fang","year":"2020","unstructured":"Fang, W. et al. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic. Biol. Med. 163, 153\u2013162 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR151","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89620","volume":"1","author":"MA Simon","year":"2016","unstructured":"Simon, M. A. et al. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction. JCI Insight 1, e89620 (2016).","journal-title":"JCI Insight"},{"key":"429_CR152","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1056\/NEJMc062800","volume":"355","author":"FJ Larsen","year":"2006","unstructured":"Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O. & Weitzberg, E. Effects of dietary nitrate on blood pressure in healthy volunteers. N. Engl. J. Med. 355, 2792\u20132793 (2006).","journal-title":"N. Engl. J. Med."},{"key":"429_CR153","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.107.103523","volume":"51","author":"AJ Webb","year":"2008","unstructured":"Webb, A. J. et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784\u2013790 (2008).","journal-title":"Hypertension"},{"key":"429_CR154","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/HJH.0000000000001305","volume":"35","author":"AW Ashor","year":"2017","unstructured":"Ashor, A. W., Lara, J. & Siervo, M. Medium-term effects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults: a systematic review and meta-analysis. J. Hypertens. 35, 1353\u20131359 (2017).","journal-title":"J. Hypertens."},{"key":"429_CR155","first-page":"355","volume":"264","author":"JK Jackson","year":"2018","unstructured":"Jackson, J. K., Patterson, A. J., MacDonald-Wicks, L. K., Oldmeadow, C. & McEvoy, M. A. The role of inorganic nitrate and nitrite in cardiovascular disease risk factors: a systematic review and meta-analysis of human evidence. Nutr. Rev. 264, 355\u2013394 (2018).","journal-title":"Nutr. Rev."},{"key":"429_CR156","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13080","volume":"224","author":"M Carlstrom","year":"2018","unstructured":"Carlstrom, M., Lundberg, J. O. & Weitzberg, E. Mechanisms underlying blood pressure reduction by dietary inorganic nitrate. Acta Physiol. 224, e13080 (2018).","journal-title":"Acta Physiol."},{"key":"429_CR157","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/joim.12441","volume":"279","author":"SA Omar","year":"2016","unstructured":"Omar, S. A., Webb, A. J., Lundberg, J. O. & Weitzberg, E. Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. J. Intern. Med. 279, 315\u2013336 (2016).","journal-title":"J. Intern. Med."},{"key":"429_CR158","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/HYPERTENSIONAHA.111.00933","volume":"61","author":"SM Ghosh","year":"2013","unstructured":"Ghosh, S. M. et al. Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 61, 1091\u20131102 (2013).","journal-title":"Hypertension"},{"key":"429_CR159","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3945\/ajcn.114.101188","volume":"102","author":"CP Bondonno","year":"2015","unstructured":"Bondonno, C. P. et al. Absence of an effect of high nitrate intake from beetroot juice on blood pressure in treated hypertensive individuals: a randomized controlled trial. Am. J. Clin. Nutr. 102, 368\u2013375 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"429_CR160","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/HYPERTENSIONAHA.114.04675","volume":"65","author":"V Kapil","year":"2015","unstructured":"Kapil, V., Khambata, R. S., Robertson, A., Caulfield, M. J. & Ahluwalia, A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension 65, 320\u2013327 (2015).","journal-title":"Hypertension"},{"key":"429_CR161","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ajcn\/nqaa024","volume":"111","author":"ML Sundqvist","year":"2020","unstructured":"Sundqvist, M. L. et al. A randomized clinical trial of the effects of leafy green vegetables and inorganic nitrate on blood pressure. Am. J. Clin. Nutr. 111, 749\u2013756 (2020).","journal-title":"Am. J. Clin. Nutr."},{"key":"429_CR162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3945\/ajcn.115.116244","volume":"103","author":"S Velmurugan","year":"2016","unstructured":"Velmurugan, S. et al. Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 103, 25\u201338 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"429_CR163","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1097\/HJH.0000000000002524","volume":"38","author":"D Li","year":"2020","unstructured":"Li, D. et al. Repeated administration of inorganic nitrate on blood pressure and arterial stiffness: a systematic review and meta-analysis of randomized controlled trials. J. Hypertens. 38, 2122\u20132140 (2020).","journal-title":"J. Hypertens."},{"key":"429_CR164","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks, F. M. et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 344, 3\u201310 (2001).","journal-title":"N. Engl. J. Med."},{"key":"429_CR165","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","volume":"336","author":"LJ Appel","year":"1997","unstructured":"Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117\u20131124 (1997).","journal-title":"N. Engl. J. Med."},{"key":"429_CR166","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrneph.2016.191","volume":"13","author":"NO Camara","year":"2017","unstructured":"Camara, N. O., Iseki, K., Kramer, H., Liu, Z. H. & Sharma, K. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat. Rev. Nephrol. 13, 181\u2013190 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR167","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon, V. & Thomson, S. C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat. Rev. Nephrol. 16, 317\u2013336 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"429_CR168","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rohde, R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329, 1456\u20131462 (1993).","journal-title":"N. Engl. J. Med."},{"key":"429_CR169","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio, G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N. Engl. J. Med. 334, 939\u2013945 (1996).","journal-title":"N. Engl. J. Med."},{"key":"429_CR170","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 (2019).","journal-title":"N. Engl. J. Med."},{"key":"429_CR171","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.119.11684","volume":"75","author":"CS Wilcox","year":"2020","unstructured":"Wilcox, C. S. Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension 75, 894\u2013901 (2020).","journal-title":"Hypertension"},{"key":"429_CR172","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacbts.2019.11.007","volume":"5","author":"LY Herat","year":"2020","unstructured":"Herat, L. Y. et al. SGLT2 inhibitor-induced sympathoinhibition: a novel mechanism for cardiorenal protection. JACC Basic. Transl. Sci. 5, 169\u2013179 (2020).","journal-title":"JACC Basic. Transl. Sci."},{"key":"429_CR173","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/377239a0","volume":"377","author":"PL Huang","year":"1995","unstructured":"Huang, P. L. et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239\u2013242 (1995).","journal-title":"Nature"},{"key":"429_CR174","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","volume":"20","author":"PL Huang","year":"2009","unstructured":"Huang, P. L. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab. 20, 295\u2013302 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"429_CR175","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2353\/ajpath.2007.060610","volume":"170","author":"MS Forbes","year":"2007","unstructured":"Forbes, M. S., Thornhill, B. A., Park, M. H. & Chevalier, R. L. Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am. J. Pathol. 170, 87\u201399 (2007).","journal-title":"Am. J. Pathol."},{"key":"429_CR176","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0002-9440(10)64957-7","volume":"156","author":"P Heeringa","year":"2000","unstructured":"Heeringa, P. et al. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am. J. Pathol. 156, 879\u2013888 (2000).","journal-title":"Am. J. Pathol."},{"key":"429_CR177","doi-asserted-by":"publisher","first-page":"F1457","DOI":"10.1152\/ajprenal.00621.2007","volume":"295","author":"Y Kanematsu","year":"2008","unstructured":"Kanematsu, Y. et al. Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats. Am. J. Physiol. Renal Physiol. 295, F1457\u2013F1462 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR178","doi-asserted-by":"publisher","first-page":"F317","DOI":"10.1152\/ajprenal.90450.2008","volume":"296","author":"T Nakayama","year":"2009","unstructured":"Nakayama, T. et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am. J. Physiol. Renal Physiol. 296, F317\u2013F327 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR179","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0002-9440(10)64175-2","volume":"161","author":"DH Kang","year":"2002","unstructured":"Kang, D. H., Nakagawa, T., Feng, L. & Johnson, R. J. Nitric oxide modulates vascular disease in the remnant kidney model. Am. J. Pathol. 161, 239\u2013248 (2002).","journal-title":"Am. J. Pathol."},{"key":"429_CR180","doi-asserted-by":"publisher","first-page":"17716","DOI":"10.1073\/pnas.1008872107","volume":"107","author":"M Carlstrom","year":"2010","unstructured":"Carlstrom, M. et al. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl Acad. Sci. USA 107, 17716\u201317720 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"429_CR181","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2018.06.007","volume":"28","author":"JO Lundberg","year":"2018","unstructured":"Lundberg, J. O., Carlstrom, M. & Weitzberg, E. Metabolic effects of dietary nitrate in health and disease. Cell Metab. 28, 9\u201322 (2018).","journal-title":"Cell Metab."},{"key":"429_CR182","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.115.018935","volume":"133","author":"YC Lai","year":"2016","unstructured":"Lai, Y. C. et al. SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction. Circulation 133, 717\u2013731 (2016).","journal-title":"Circulation"},{"key":"429_CR183","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/db19-0892","volume":"69","author":"BD McNally","year":"2020","unstructured":"McNally, B. D. et al. Inorganic nitrate promotes glucose uptake and oxidative catabolism in white adipose tissue through the XOR-catalyzed nitric oxide pathway. Diabetes 69, 893\u2013901 (2020).","journal-title":"Diabetes"},{"key":"429_CR184","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1113\/JP270386","volume":"593","author":"S Singamsetty","year":"2015","unstructured":"Singamsetty, S. et al. Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model of obesity and insulin resistance. J. Physiol. 593, 3135\u20133145 (2015).","journal-title":"J. Physiol."},{"key":"429_CR185","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/cvr\/cvt224","volume":"101","author":"C Kamga Pride","year":"2014","unstructured":"Kamga Pride, C. et al. Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia\/reperfusion. Cardiovasc. Res. 101, 57\u201368 (2014).","journal-title":"Cardiovasc. Res."},{"key":"429_CR186","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.freeradbiomed.2020.09.018","volume":"160","author":"CH Moretti","year":"2020","unstructured":"Moretti, C. H. et al. Dietary nitrite extends lifespan and prevents age-related locomotor decline in the fruit fly. Free Radic. Biol. Med. 160, 860\u2013870 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR187","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12986-015-0013-6","volume":"12","author":"Z Bahadoran","year":"2015","unstructured":"Bahadoran, Z., Ghasemi, A., Mirmiran, P., Azizi, F. & Hadaegh, F. Beneficial effects of inorganic nitrate\/nitrite in type 2 diabetes and its complications. Nutr. Metab. 12, 16 (2015).","journal-title":"Nutr. Metab."},{"key":"429_CR188","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2013.01.024","volume":"60","author":"M Gilchrist","year":"2013","unstructured":"Gilchrist, M. et al. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic. Biol. Med. 60, 89\u201397 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR189","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.niox.2020.12.005","volume":"107","author":"Z Bahadoran","year":"2020","unstructured":"Bahadoran, Z. et al. Effect of inorganic nitrate on metabolic parameters in patients with type 2 diabetes: A 24-week randomized double-blind placebo-controlled clinical trial. Nitric Oxide 107, 58\u201365 (2020).","journal-title":"Nitric Oxide"},{"key":"429_CR190","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest."},{"key":"429_CR191","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.niox.2020.01.013","volume":"97","author":"I Cordero-Herrera","year":"2020","unstructured":"Cordero-Herrera, I. et al. Head-to-head comparison of inorganic nitrate and metformin in a mouse model of cardiometabolic disease. Nitric Oxide 97, 48\u201356 (2020).","journal-title":"Nitric Oxide"},{"key":"429_CR192","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.120.14930","volume":"76","author":"KS Hughan","year":"2020","unstructured":"Hughan, K. S. et al. Effects of oral sodium nitrite on blood pressure, insulin sensitivity, and intima-media arterial thickening in adults with hypertension and metabolic syndrome. Hypertension 76, 866\u2013874 (2020).","journal-title":"Hypertension"},{"key":"429_CR193","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/0971-4065.147376","volume":"25","author":"YS Reddy","year":"2015","unstructured":"Reddy, Y. S. et al. Nitric oxide status in patients with chronic kidney disease. Indian J. Nephrol. 25, 287\u2013291 (2015).","journal-title":"Indian J. Nephrol."},{"key":"429_CR194","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2013.01.020","volume":"58","author":"NS Bryan","year":"2013","unstructured":"Bryan, N. S. et al. Acute effects of hemodialysis on nitrite and nitrate: potential cardiovascular implications in dialysis patients. Free Radic. Biol. Med. 58, 46\u201351 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2016.05.005","volume":"58","author":"M Carlstrom","year":"2016","unstructured":"Carlstrom, M. et al. Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia. Nitric Oxide 58, 1\u20139 (2016).","journal-title":"Nitric Oxide"},{"key":"429_CR196","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ckj\/sfv009","volume":"8","author":"M Carlstrom","year":"2015","unstructured":"Carlstrom, M. et al. Plasma nitrate\/nitrite removal by peritoneal dialysis might predispose infants with low blood pressure to cerebral ischaemia. Clin. Kidney J. 8, 215\u2013218 (2015).","journal-title":"Clin. Kidney J."},{"key":"429_CR197","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.niox.2020.02.004","volume":"98","author":"A Heredia Martinez","year":"2020","unstructured":"Heredia Martinez, A. et al. Removal of nitrate and nitrite by hemodialysis in end-stage renal disease and by sustained low-efficiency dialysis in acute kidney injury. Nitric Oxide 98, 33\u201340 (2020).","journal-title":"Nitric Oxide"},{"key":"429_CR198","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cvr\/cvq366","volume":"89","author":"M Carlstrom","year":"2011","unstructured":"Carlstrom, M. et al. Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. Cardiovasc. Res. 89, 574\u2013585 (2011).","journal-title":"Cardiovasc. Res."},{"key":"429_CR199","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.114.04222","volume":"65","author":"X Gao","year":"2015","unstructured":"Gao, X. et al. NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite. Hypertension 65, 161\u2013170 (2015).","journal-title":"Hypertension"},{"key":"429_CR200","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.118.12425","volume":"73","author":"DD Guimaraes","year":"2019","unstructured":"Guimaraes, D. D. et al. Dietary nitrate reduces blood pressure in rats with angiotensin II-induced hypertension via mechanisms that involve reduction of sympathetic hyperactivity. Hypertension 73, 839\u2013848 (2019).","journal-title":"Hypertension"},{"key":"429_CR201","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2016.07.025","volume":"99","author":"M Hezel","year":"2016","unstructured":"Hezel, M. et al. Dietary nitrate improves age-related hypertension and metabolic abnormalities in rats via modulation of angiotensin II receptor signaling and inhibition of superoxide generation. Free Radic. Biol. Med. 99, 87\u201398 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"429_CR202","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1681\/ASN.2006050450","volume":"18","author":"P Tripatara","year":"2007","unstructured":"Tripatara, P. et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia\/reperfusion injury in vivo: role for xanthine oxidoreductase. J. Am. Soc. Nephrol. 18, 570\u2013580 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR203","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.redox.2017.06.002","volume":"13","author":"T Yang","year":"2017","unstructured":"Yang, T. et al. Dietary nitrate attenuates renal ischemia-reperfusion injuries by modulation of immune responses and reduction of oxidative stress. Redox Biol. 13, 320\u2013330 (2017).","journal-title":"Redox Biol."},{"key":"429_CR204","doi-asserted-by":"publisher","first-page":"F378","DOI":"10.1152\/ajprenal.00400.2016","volume":"313","author":"JB Rosenbaek","year":"2017","unstructured":"Rosenbaek, J. B. et al. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study. Am. J. Physiol. Renal Physiol. 313, F378\u2013F387 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"429_CR205","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HJH.0000000000001598","volume":"36","author":"JB Rosenbaek","year":"2018","unstructured":"Rosenbaek, J. B. et al. Effects of sodium nitrite on renal function and blood pressure in hypertensive vs. healthy study participants: a randomized, placebo-controlled, crossover study. J. Hypertens. 36, 666\u2013679 (2018).","journal-title":"J. Hypertens."},{"key":"429_CR206","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-018-1035-x","volume":"19","author":"JB Rosenbaek","year":"2018","unstructured":"Rosenbaek, J. B., Pedersen, E. B. & Bech, J. N. The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study. BMC Nephrol. 19, 244 (2018).","journal-title":"BMC Nephrol."},{"key":"429_CR207","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1249\/MSS.0000000000000548","volume":"47","author":"A Carpentier","year":"2015","unstructured":"Carpentier, A., Stragier, S., Brejeon, C. & Poortmans, J. R. Nitrate supplementation, exercise, and kidney function: are there detrimental effects? Med. Sci. Sports Exerc. 47, 1519\u20131522 (2015).","journal-title":"Med. Sci. Sports Exerc."},{"key":"429_CR208","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1681\/ASN.2020030384","volume":"32","author":"JT Kelly","year":"2021","unstructured":"Kelly, J. T. et al. Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis. J. Am. Soc. Nephrol. 32, 239\u2013253 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"429_CR209","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.niox.2017.01.011","volume":"64","author":"S Kemmner","year":"2017","unstructured":"Kemmner, S. et al. Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide 64, 7\u201315 (2017).","journal-title":"Nitric Oxide"},{"key":"429_CR210","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/nu8120811","volume":"8","author":"Z Bahadoran","year":"2016","unstructured":"Bahadoran, Z. et al. Association between dietary intakes of nitrate and nitrite and the risk of hypertension and chronic kidney disease: tehran lipid and glucose study. Nutrients 8, 811 (2016).","journal-title":"Nutrients"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00429-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:44:17Z","timestamp":1733939057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00429-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":210,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1038\/s41581-021-00429-z","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"15 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}